SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17200360
Source:
http://linkedlifedata.com/resource/pubmed/id/17200360
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007095
,
umls-concept:C0205179
,
umls-concept:C0205210
,
umls-concept:C0681828
,
umls-concept:C0935989
pubmed:issue
1
pubmed:dateCreated
2007-1-3
pubmed:abstractText
Effective systemic therapy options for carcinoid tumors are lacking. We conducted in vitro studies and a phase II clinical trial to explore the activity of imatinib in carcinoid tumors.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines
,
http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1078-0432
pubmed:author
pubmed-author:AbbruzzeseJames LJL
,
pubmed-author:AjaniJaffer AJA
,
pubmed-author:EllisLeeL
,
pubmed-author:HessKennethK
,
pubmed-author:RashidAsifA
,
pubmed-author:SzklarukJanioJ
,
pubmed-author:XieKepingK
,
pubmed-author:YaoJames CJC
,
pubmed-author:YeungSai-Ching JSC
,
pubmed-author:ZhangJun XJX
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
234-40
pubmed:meshHeading
pubmed-meshheading:17200360-Adult
,
pubmed-meshheading:17200360-Aged
,
pubmed-meshheading:17200360-Antineoplastic Agents
,
pubmed-meshheading:17200360-Carcinoid Tumor
,
pubmed-meshheading:17200360-Cell Line, Tumor
,
pubmed-meshheading:17200360-Disease-Free Survival
,
pubmed-meshheading:17200360-Dose-Response Relationship, Drug
,
pubmed-meshheading:17200360-Female
,
pubmed-meshheading:17200360-Humans
,
pubmed-meshheading:17200360-Immunohistochemistry
,
pubmed-meshheading:17200360-Male
,
pubmed-meshheading:17200360-Middle Aged
,
pubmed-meshheading:17200360-Piperazines
,
pubmed-meshheading:17200360-Pyrimidines
,
pubmed-meshheading:17200360-Time Factors
,
pubmed-meshheading:17200360-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Clinical and in vitro studies of imatinib in advanced carcinoid tumors.
pubmed:affiliation
Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. jyao@mdanderson.org
pubmed:publicationType
Journal Article
,
In Vitro
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II